Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Heal...
Saved in:
Other Authors: | , , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_69153 | ||
005 | 20210501 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20210501s2020 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-03936-659-0 | ||
020 | |a 9783039366583 | ||
020 | |a 9783039366590 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-03936-659-0 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Ferraris, Davide Maria |4 edt | |
700 | 1 | |a Miggiano, Riccardo |4 edt | |
700 | 1 | |a Rizzi, Menico |4 edt | |
700 | 1 | |a Ferraris, Davide Maria |4 oth | |
700 | 1 | |a Miggiano, Riccardo |4 oth | |
700 | 1 | |a Rizzi, Menico |4 oth | |
245 | 1 | 0 | |a Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
300 | |a 1 electronic resource (128 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled "Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment" that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a Mycobacterium tuberculosis | ||
653 | |a line probe assay | ||
653 | |a second-line drugs | ||
653 | |a drug resistance | ||
653 | |a XDR-TB | ||
653 | |a MDR-TB | ||
653 | |a omics analysis | ||
653 | |a TB treatment | ||
653 | |a system analysis | ||
653 | |a Beijing B0/W148 | ||
653 | |a Mycobacterium smegmatis | ||
653 | |a imidazo[1,2-b][1,2,4,5]tetrazine | ||
653 | |a MmpS5-MmpL5 | ||
653 | |a efflux | ||
653 | |a drug discovery | ||
653 | |a tuberculosis | ||
653 | |a immune activation | ||
653 | |a HLA-DR | ||
653 | |a CD38 | ||
653 | |a treatment response | ||
653 | |a Mycobacterium | ||
653 | |a macrophage | ||
653 | |a apoptosis | ||
653 | |a effector | ||
653 | |a cytokine | ||
653 | |a microRNA | ||
653 | |a Beijing genotype | ||
653 | |a Central Asia Outbreak | ||
653 | |a murine infection model | ||
653 | |a Virulence | ||
653 | |a pre-XDR-TB | ||
653 | |a Mycobacterium avium | ||
653 | |a unique metabolic pathways | ||
653 | |a subtractive genomics | ||
653 | |a drug target | ||
653 | |a uncharacterized proteins | ||
653 | |a BM-MSCs | ||
653 | |a Mtb | ||
653 | |a bone-homing | ||
653 | |a stem cell niche | ||
653 | |a latent tuberculosis | ||
653 | |a relapse | ||
653 | |a liposomes | ||
653 | |a M. tuberculosis | ||
653 | |a host-pathogen interactions | ||
653 | |a immune response | ||
653 | |a antitubercular drug discovery | ||
653 | |a antitubercular treatments | ||
653 | |a IL-18 | ||
653 | |a IL-18BP | ||
653 | |a IL-18R | ||
653 | |a gene expression | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2925 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/69153 |7 0 |z DOAB: description of the publication |